VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 28 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,027 | -92.7% | 28,321 | -89.1% | 0.00% | -100.0% |
| Q2 2023 | $1,503,743 | +129756.9% | 260,614 | +46.2% | 0.00% | 0.0% |
| Q1 2023 | $1,158 | +105.0% | 178,212 | -13.3% | 0.00% | – |
| Q4 2022 | $565 | -99.7% | 205,446 | +177.4% | 0.00% | – |
| Q3 2022 | $216,000 | -16.0% | 74,074 | -44.6% | 0.00% | – |
| Q2 2022 | $257,000 | -67.6% | 133,734 | +36.9% | 0.00% | – |
| Q1 2022 | $792,000 | -8.2% | 97,707 | +3.7% | 0.00% | – |
| Q4 2021 | $863,000 | +314.9% | 94,220 | +466.6% | 0.00% | – |
| Q3 2021 | $208,000 | -94.2% | 16,630 | -94.8% | 0.00% | -100.0% |
| Q2 2021 | $3,611,000 | +613.6% | 319,552 | +856.2% | 0.00% | – |
| Q1 2021 | $506,000 | -86.9% | 33,418 | -90.0% | 0.00% | -100.0% |
| Q4 2020 | $3,860,000 | +37.4% | 335,318 | -7.6% | 0.00% | 0.0% |
| Q3 2020 | $2,809,000 | +453.0% | 362,969 | +1309.6% | 0.00% | +200.0% |
| Q2 2018 | $508,000 | – | 25,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
| Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
| Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
| Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
| Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
| Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
| CONNING INC. | 129,013 | $1,051,000 | 0.04% |